Sean Grant
Fortune : 2 M $ au 31/08/2026
Fortune : 2 M $ au 31/08/2026
Sean P.
Grant is currently Chief Financial Officer at Vera Therapeutics, Inc. since 2021.
Formerly, Mr. Grant was VP-Corporate Strategy & Business Development at CareDx, Inc. from 2020 to 2021 and Vice President-Investment Banking Healthcare at Citigroup, Inc. from 2015 to 2020.
Mr. Grant completed undergraduate studies at George Mason University and earned an MBA from Carey Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/03/2026 | 61 913 ( 0,09% ) | 2 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VERA THERAPEUTICS, INC. | Directeur Financier/CFO | 12/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| CAREDX, INC. | Corporate Officer/Principal | 01/06/2021 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/03/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
George Mason University
George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carey Business School
Carey Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national